NEOGENOMICS
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and pharmaceutical firms in Europe and Asia.
NEOGENOMICS
Industry:
Biotechnology Genetics Health Care Health Diagnostics Medical Pharmaceutical
Founded:
1998-10-29
Address:
Fort Myers, Florida, United States
Country:
United States
Website Url:
http://www.neogenomics.com
Total Employee:
501+
Status:
Active
Contact:
(239) 768-0600
Email Addresses:
[email protected]
Total Funding:
350.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving Nginx Amazon ReCAPTCHA
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Cure Forward
Cure Forward helps cancer patients and physicians access advanced treatments in oncology.
Gravity Diagnostics
Gravity Diagnostics is a full-service state-of-the-art CLIA laboratory licensed in all 50 states providing innovative laboratory testing.
IceCure Medical Ltd.
IceCure is a medical device company setting new standards in minimally-invasive tumor therapy women’s health and interventional oncology.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Vireo Health
Vireo Health is a medical marijuana dispensary.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-05-05 | Inivata | Inivata acquired by NeoGenomics | N/A |
| 2021-03-24 | Trapelo Health | Trapelo Health acquired by NeoGenomics | 65 M USD |
| 2018-10-23 | Genoptix | Genoptix acquired by NeoGenomics | N/A |
| 2015-10-21 | Clarient | Clarient acquired by NeoGenomics | N/A |
| 2014-07-08 | Path Logic | Path Logic acquired by NeoGenomics | 6 M USD |
Investors List
Woodline Partners
Woodline Partners investment in Post-IPO Equity - NeoGenomics
Federated Kaufmann Fund
Federated Kaufmann Fund investment in Post-IPO Equity - NeoGenomics
Blue Water Life Science Fund
Blue Water Life Science Fund investment in Post-IPO Equity - NeoGenomics
RTW Investments LLC
RTW Investments LLC investment in Post-IPO Equity - NeoGenomics
Soleus Capital
Soleus Capital investment in Post-IPO Equity - NeoGenomics
Driehaus Capital Management
Driehaus Capital Management investment in Post-IPO Equity - NeoGenomics
First Light Asset Management
First Light Asset Management investment in Post-IPO Equity - NeoGenomics
Janus Henderson Investors
Janus Henderson Investors investment in Post-IPO Equity - NeoGenomics
Pura Vida Investments
Pura Vida Investments investment in Post-IPO Equity - NeoGenomics
Casdin Capital
Casdin Capital investment in Post-IPO Equity - NeoGenomics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-05-26 | Inivata | NeoGenomics investment in Corporate Round - Inivata | 25 M USD |
Newest Events participated
Key Employee Changes
Official Site Inspections
http://www.neogenomics.com Semrush global rank: 583 K Semrush visits lastest month: 79.21 K
- Host name: 23.185.0.2
- IP address: 23.185.0.2
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "NeoGenomics"
NeoGenomics Laboratories
NeoGenomics is a leader in precision oncology testing, empowering healthcare experts to optimize patient care.See details»
About | NeoGenomics Laboratories
NeoGenomics is comprised of an international team of physicians, scientists, and laboratory professionals, who work in partnership with cancer care teams to deliver vital oncology …See details»
NeoGenomics, Inc. (NEO)
Nov 19, 2024 · NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United …See details»
Patients | NeoGenomics Laboratories
NeoGenomics is dedicated to increasing and improving access to care and advancing patient outcomes through transformative oncology testing. Our mission: Save lives through improved patient care.See details»
NeoGenomics | The Org
NeoGenomics Laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over …See details»
NeoGenomics - Wikipedia
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is a high-complexity CLIA -certified clinical laboratory, pharma services and information services company that …See details»
NeoGenomics - Crunchbase Company Profile & Funding
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists. NeoGenomics reported a 68% loss for its shareholders over the past three years. In the first quarter of …See details»
Board of Directors :: NeoGenomics, Inc. (NEO)
With 40 years of executive leadership in medical device and health care services, David Perez serves as an independent board member and advisor to several corporations and non-profit organizations.See details»
NeoGenomics Laboratories - LinkedIn
NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world for physicians to help them...See details»
Our Team | NeoGenomics Laboratories
Through our expertise, customization, and scalability, NeoGenomics supports clients in cancer-related market segments, including hospital and private pathology laboratories, office-based oncologists, academic institutions, …See details»
Company Profile: NeoGenomics Laboratories, Inc. - Taylor
Nov 20, 2012 · NeoGenomics Laboratories, Inc. is a publicly traded high-complexity national clinical laboratory company that specializes in cancer diagnostic testing, focused on molecular …See details»
Company Information :: NeoGenomics, Inc. (NEO)
NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world for physicians to help …See details»
NeoGenomics Mission, Benefits, and Work Culture | Indeed.com
Come see what’s going on inside NeoGenomics, including the company culture, employee work-life benefits, and business goals. Discover all the key insights that make people want to work …See details»
NeoGenomics Expands Board of Directors with Appointments of …
MYERS, FL / ACCESSWIRE / June 29, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, today announced the …See details»
NeoGenomics Company Overview
NeoGenomics is a premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative …See details»
NeoGenomics, Inc. Expands Its Global Strategic Partnership …
Apr 11, 2022 · The Global Strategic Partnership between NeoGenomics and Biognosys AG will encompass multiple strategic and commercial initiatives including NeoGenomics' labs offering …See details»
Diagnostic - NGS | NeoGenomics Laboratories
NeoGenomics provides NGS testing that spans from single gene testing, targeted profile testing, broad-reach tumor testing, liquid biopsy and beyond.See details»
Press Releases :: NeoGenomics, Inc. (NEO)
NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized TreatmentSee details»
NeoGenomics Reports Full Year Revenue of $484 Million and $126 …
In 2021, our labs processed almost 1.1 million clinical tests, generated revenue from over 1,000 pharma projects and ended the year with $484 million in consolidated revenue representing …See details»
Newsroom | NeoGenomics Laboratories
Nov 9, 2024 · NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized TreatmentSee details»